Conference
Phase II trial of cytoreductive stereotactic hypofractionated radiotherapy with combination ipilimumab/nivolumab for metastatic kidney cancer (CYTOSHRINK)
Authors
Lalani A-KA; Swaminath A; Pond GR; Kapoor A; Chu W; Bramson JL; Surette MG; Levine MN; Hotte SJ
Volume
38
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Publication Date
February 20, 2020
Name of conference
Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO)
Conference place
CA, San Francisco
Conference start date
February 13, 2020
Conference end date
February 15, 2020
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
6
ISSN
0732-183X